Rockwell Medical provides update on IV Triferic
Rockwell Medical reported the Company is in the process of preparing a New Drug Application for IV Triferic and anticipates that it will file the NDA in the fourth quarter of 2018, which would result in a Prescription Drug User Fee Act action date in late 2019. October 12, 2018